Skip to content
lifestyle.fictiontalk.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Halia Therapeutics
Halia Therapeuticsto Participate in the 6th Annual Needham Private Biotech & MedTech Company Virtual 1×1 Forum
October 7, 2026
Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
September 9, 2026
Halia Therapeutics Presents Two AAIC 2026 Posters on HT-4253 for Alzheimer’s Prevention in APOE4 Carriers
July 13, 2026
Halia Therapeutics Receives FDA Fast Track Designation for Ofirnoflast (HT-6184) in Lower-Risk Myelodysplastic Syndromes
June 15, 2026
Halia Therapeutics Appoints Gary Sabin as Executive Chairman and Adds Three Independent Directors to Board
May 19, 2026
Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
May 12, 2026